The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Immature truncated O-glycophenotype of cancer directly induces oncogenic features
Open accessAbstract
Significance: Cancer cells characteristically express proteins with immature O-glycosylation, but how and why cancer cells express immature O-glycans has remained poorly understood. Here, we report that one prevalent mechanism in pancreatic cancer is epigenetic silencing, rather than somatic mutations in a key chaperone, core 1 β3-Gal-T-specific molecular chaperone (COSMC), required for mature elongated O-glycosylation. We also demonstrate, with the use of well-defined cell systems generated by precise gene editing, that the aberrant O-glycophenotype by itself induces oncogenic features with enhanced growth and invasion. Our study suggests that the characteristic aberrant O-glycophenotype is critical for the development and behavior of cancer and further provides support for immunotherapeutic strategies that target aberrant O-glycans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,905
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.
Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., & Fusenig, N. E. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.3.761 · Cited by 4,170
Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks
Olsen, J. V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P., & Mann, M. (2006) · Cell · doi:10.1016/j.cell.2006.09.026 · Cited by 3,499
Self-citationGlycosylation in Cellular Mechanisms of Health and Disease
Ohtsubo, K., & Marth, J. D. (2006) · Cell · doi:10.1016/j.cell.2006.08.019 · Cited by 2,788
MethPrimer: designing primers for methylation PCRs
Li, L.-C., & Dahiya, R. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.11.1427 · Cited by 2,729
CD44: From adhesion molecules to signalling regulators
Ponta, H., Sherman, L., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,386
Vertebrate protein glycosylation: diversity, synthesis and function
Moremen, K. W., Tiemeyer, M., & Nairn, A. V. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3383 · Cited by 1,677
Breitling, R., Armengaud, P., Amtmann, A., & Herzyk, P. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.055 · Cited by 1,496
Precision mapping of the human O‐GalNAc glycoproteome through SimpleCell technology
Steentoft, C., Vakhrushev, S. Y., Joshi, H. J., Kong, Y., Vester‐Christensen, M. B., Schjoldager, K. T. G., Lavrsen, K., Dabelsteen, S., Pedersen, N. B., Marcos‐Silva, L., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.79 · Cited by 1,408
Self-citationProgression model for pancreatic cancer.
Hruban, R. H., Goggins, M., Parsons, J., & Kern, S. E. (2000) · PubMed · Cited by 1,102
T and Tn, General Carcinoma Autoantigens
Springer, G. F. (1984) · Science · doi:10.1126/science.6729450 · Cited by 1,009
Higher-energy C-trap dissociation for peptide modification analysis
Olsen, J. V., Macek, B., Lange, O., Makarov, A., Horning, S., & Mann, M. (2007) · Nature Methods · doi:10.1038/nmeth1060 · Cited by 999
Self-citationBennett, E. P., Mandel, U., Clausen, H., Gerken, T. A., Fritz, T. A., & Tabak, L. A. (2012) · Glycobiology · doi:10.1093/glycob/cwr182 · Cited by 876
Self-citationJu, T., & Cummings, R. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262438199 · Cited by 487
Stanley, P. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005199 · Cited by 455
Rigbolt, K. T. G., Prokhorova, T. A., Akimov, V., Henningsen, J., Johansen, P. T., Kratchmarova, I., Kassem, M., Mann, M., Olsen, J. V., & Blagoev, B. (2011) · Science Signaling · doi:10.1126/scisignal.2001570 · Cited by 451
Self-citationHakomori, S.-I. (2001) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-1267-7_24 · Cited by 448
Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy
Springer, G. F. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050144 · Cited by 426
Pellegata, N. S., Sessa, F., Renault, B., Bonato, M., Leone, B. E., Solcia, E., & Ranzani, G. N. (1994) · PubMed · Cited by 387
Mining the O-glycoproteome using zinc-finger nuclease–glycoengineered SimpleCell lines
Steentoft, C., Vakhrushev, S. Y., Vester-Christensen, M. B., Schjoldager, K. T.-B. G., Kong, Y., Bennett, E. P., Mandel, U., Wandall, H., Levery, S. B., & Clausen, H. (2011) · Nature Methods · doi:10.1038/nmeth.1731 · Cited by 349
Self-citationMucin-type O-glycosylation and its potential use in drug and vaccine development
Tarp, M. A., & Clausen, H. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.09.010 · Cited by 303
Self-citationHuman Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc
Ju, T., Lanneau, G. S., Gautam, T., Wang, Y., Xia, B., Stowell, S. R., Willard, M. T., Wang, W., Xia, J. Y., Zuna, R. E., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2345 · Cited by 292
Chaperone mutation in Tn syndrome
Ju, T., & Cummings, R. D. (2005) · Nature · doi:10.1038/4371252a · Cited by 271
Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes
Wandall, H. H., Blixt, O., Tarp, M. A., Pedersen, J. W., Bennett, E. P., Mandel, U., Ragupathi, G., Livingston, P. O., Hollingsworth, M. A., Taylor-Papadimitriou, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2893 · Cited by 266
Self-citationSewell, R., Bäckström, M., Dalziel, M., Gschmeissner, S., Karlsson, H., Noll, T., Gätgens, J., Clausen, H., Hansson, G. C., Burchell, J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511826200 · Cited by 258
Self-citationMarcos, N. T., Pinho, S., Grandela, C., Cruz, A., Samyn-Petit, B., Harduin-Lepers, A., Almeida, R., Silva, F., Morais, V., Costa, J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1921 · Cited by 258
Self-citationKim, G. E., Bae, H., Park, H., Kuan, S., Crawley, S. C., Ho, J. J. L., & Kim, Y. S. (2002) · Gastroenterology · doi:10.1053/gast.2002.36018 · Cited by 252
Tumorigenic conversion of immortal human keratinocytes through stromal cell activation
Skobe, M., & Fusenig, N. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1050 · Cited by 233
Oligosaccharides Expressed on MUC1 Produced by Pancreatic and Colon Tumor Cell Lines
Burdick, M. D., Harris, A., Reid, C. J., Iwamura, T., & Hollingsworth, M. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24198 · Cited by 215
Self-citationCosmc is an essential chaperone for correct protein O-glycosylation
Wang, Y., Ju, T., Ding, X., Xia, B., Wang, W., Xia, L., He, M., & Cummings, R. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914004107 · Cited by 212
Boukamp, P., Stanbridge, E. J., Foo, D., Cerutti, P., & Fusenig, N. E. (1990) · PubMed · Cited by 212
Regulation of O -glycosylation through Golgi-to-ER relocation of initiation enzymes
Gill, D. J., Chia, J., Senewiratne, J., & Bard, F. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201003055 · Cited by 204
Schjoldager, K. T.-B. G., & Clausen, H. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.09.014 · Cited by 193 · cited 1×
“The possibilities include coregulatory roles of glycans on regulated ectodomain shedding (53), as well as an influence on receptor homodimerization (56).”
BackgroundSelf-citationGill, D. J., Tham, K. M., Chia, J., Wang, S. C., Steentoft, C., Clausen, H., Bard-Chapeau, E. A., & Bard, F. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305269110 · Cited by 191
Self-citationTn and sialyl‐Tn antigens, aberrant O‐glycomics as human disease markers
Ju, T., Wang, Y., Aryal, R. P., Lehoux, S. D., Ding, X., Kudelka, M. R., Cutler, C., Zeng, J., Wang, J., Sun, X., et al. (2013) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201300024 · Cited by 164
A Mutant Chaperone Converts a Wild-Type Protein into a Tumor-Specific Antigen
Schietinger, A., Philip, M., Yoshida, B. A., Azadi, P., Liu, H., Meredith, S. C., & Schreiber, H. (2006) · Science · doi:10.1126/science.1129200 · Cited by 160
Boukamp, P., Popp, S., Altmeyer, S., Hülsen, A., Fasching, C. L., Cremer, T. J., & Fusenig, N. E. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199708)19:4<201::aid-gcc1>3.0.co;2-0 · Cited by 152
Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiation
Harmon, R. M., Simpson, C. L., Johnson, J. L., Koetsier, J. L., Dubash, A. D., Najor, N. A., Sarig, O., Sprecher, E., & Green, K. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65220 · Cited by 151
Axelsson, M., Karlsson, N. G., Steel, D. M., Ouwendijk, J., Nilsson, T., & Hansson, G. C. (2001) · Glycobiology · doi:10.1093/glycob/11.8.633 · Cited by 146
Lederle, W., Depner, S., Schnur, S., Obermueller, E., Catone, N., Just, A., Fusenig, N. E., & Mueller, M. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25621 · Cited by 143
Epidermal differentiation and basement membrane formation by HaCaT cells in surface transplants
Breitkreutz, D., Schoop, V. M., Mirancea, N., Baur, M., Stark, H., & Fusenig, N. E. (1998) · European Journal of Cell Biology · doi:10.1016/s0171-9335(98)80123-4 · Cited by 138
Ju, T., Aryal, R. P., Stowell, C. J., & Cummings, R. D. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200711151 · Cited by 135
Hassinen, A., Pujol, F. M., Kokkonen, N., Pieters, C., Kihlström, M., Korhonen, K., & Kellokumpu, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277681 · Cited by 131 · cited 1×
“mechanisms, including altered expression of glycosyltransferases acting in the processing step (17), somatic mutations or hypermethylation of COSMC (13–15, 18), relocation of polypeptide GalNAc-transferases from Golgi to endoplasmic reticulum (ER) (19, 20), general reorganization of glycosyltransferase topology (19, 2…”
BackgroundExpression of Tn, sialosyl Tn, and T antigens in human pancreas
Itzkowitz, S. H., Kjeldsen, T., Friera, A. M., Hakomori, S., Yang, U.-S., & Kim, Y. S. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90671-7 · Cited by 126
Obermueller, E., Vosseler, S., Fusenig, N. E., & Mueller, M. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3301 · Cited by 117
Enhanced Mass Spectrometric Mapping of the Human GalNAc-type O-Glycoproteome with SimpleCells
Vakhrushev, S. Y., Steentoft, C., Vester-Christensen, M. B., Bennett, E., Clausen, H., & Levery, S. B. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o112.021972 · Cited by 109
Self-citationBreitkreutz, D., Stark, H., Plein, P., Baur, M., & Fusenig, N. E. (1993) · Differentiation · doi:10.1111/j.1432-0436.1993.tb01602.x · Cited by 102
Margulis, A. R., Zhang, W., Alt‐Holland, A., Crawford, H. C., Fusenig, N. E., & Garlick, J. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3399 · Cited by 95
Spindler, V., Rötzer, V., Dehner, C. A., Kempf, B., Gliem, M., Radeva, M. Y., Hartlieb, E., Harms, G. S., Schmidt, E., & Waschke, J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci60139 · Cited by 95
Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis
Hlady, R. A., Nováková, S., Opavska, J., Klinkebiel, D. L., Peters, S. L., Bies, J., Hannah, J. D., Iqbal, J., Anderson, K. M., Siebler, H. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57292 · Cited by 93
Self-citationLavrsen, K., Madsen, C. B., Rasch, M. G., Woetmann, A., Ødum, N., Mandel, U., Clausen, H., Pedersen, A. E., & Wandall, H. H. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-012-9437-7 · Cited by 81
Self-citationTumorigenic conversion of immortal human skin keratinocytes (HaCaT) by elevated temperature
Boukamp, P., Popp, S., Bleuel, K., Tomakidi, E., Bürkle, A., & Fusenig, N. E. (1999) · Oncogene · doi:10.1038/sj.onc.1202934 · Cited by 81
Mechanisms regulating epidermal stem cells
Beck, B., & Blanpain, C. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.67 · Cited by 80
Breitkreutz, D., Boukamp, P., Ryle, C. M., Stark, H., Roop, D. R., & Fusenig, N. E. (1991) · PubMed · Cited by 69
Maxson, J. E., Luty, S. B., MacManiman, J. D., Abel, M. L., Druker, B. J., & Tyner, J. W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.508440 · Cited by 67
Lederle, W., Stark, H., Skobe, M., Fusenig, N. E., & Mueller, M. M. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060120 · Cited by 64
Epigenetic Silencing of the Chaperone Cosmc in Human Leukocytes Expressing Tn Antigen
Mi, R., Song, L., Wang, Y., Ding, X., Zeng, J., Lehoux, S. D., Aryal, R. P., Wang, J., Crew, V. K., van Die, I., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.371989 · Cited by 63
Dabelsteen, S., Hercule, P., Barron, P., Rice, M. A., Dorsainville, G., & Rheinwald, J. G. (2009) · Stem Cells · doi:10.1002/stem.64 · Cited by 56
Self-citationPinpointing Phosphorylation Sites: Quantitative Filtering and a Novel Site-specific x-Ion Fragment
Kelstrup, C. D., Hekmat, O., Francavilla, C., & Olsen, J. V. (2011) · Journal of Proteome Research · doi:10.1021/pr200154t · Cited by 38
Self-citationRadhakrishnan, P., Grandgenett, P. M., Mohr, A. M., Bunt, S. K., Yu, F., Chowdhury, S., & Hollingsworth, M. A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28322 · Cited by 36
Self-citationA Tumor-Associated Antigen in Carcinoma of the Pancreas Defined by Monoclonal Antibody B72.3
Lyubsky, S. L., Madariaga, J., Lozowski, M., et al. (1988) · American Journal of Clinical Pathology · doi:10.1093/ajcp/89.2.160 · Cited by 32
Carbohydrate clearance receptors in transfusion medicine
Sørensen, A. L. T., Clausen, H., & Wandall, H. H. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.07.008 · Cited by 29
Self-citationMargulis, A. R., Andriani, F., Fusenig, N. E., Hashimoto, K., Hanakawa, Y., & Garlick, J. A. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12523.x · Cited by 24
Cited by
Glycosylation in cancer: mechanisms and clinical implications
Pinho, S. S., & Reis, C. A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3982 · Cited by 3,083
Global view of human protein glycosylation pathways and functions
Schjoldager, K. T., Narimatsu, Y., Joshi, H. J., & Clausen, H. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00294-x · Cited by 1,309
Self-citationProtein Glycosylation in Cancer
Stowell, S. R., Ju, T., & Cummings, R. D. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040438 · Cited by 873
Posey, A. D., Schwab, R. D., Boesteanu, A. C., Steentoft, C., Mandel, U., Engels, B., Stone, J. D., Madsen, T. D., Schreiber, K., Haines, K. M., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.014 · Cited by 594
Self-citationHallmarks of glycosylation in cancer
Munkley, J., & Elliott, D. J. (2016) · Oncotarget · doi:10.18632/oncotarget.8155 · Cited by 521
Metadata
- Authors
- Radhakrishnan, P., Dabelsteen, S., Madsen, F. B., Francavilla, C., Kopp, K. L., Steentoft, C., Vakhrushev, S. Y., Olsen, J. V., Hansen, L., Bennett, E. P., Woetmann, A., Yin, G., Chen, L., Song, H., Bak, M., Hlady, R. A., Peters, S. L., Opavsky, R., Thode, C., Qvortrup, K., Schjoldager, K. T.-B. G., Clausen, H., Hollingsworth, M. A., & Wandall, H. H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2014-08-12
- Volume
- 111
- Issue
- 39
- Pages
- E4066-75
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2075253368
- Cited by
- 313
- References
- 65
- FWCI
- 8.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.